At Comosystems, we have been working for 30 years to understand how artificial electromagnetic fields (EMFs) and to developing solutions that minimize their biological
impact. As exposure to EMFs grows worldwide, we remain committed to addressing this critical form of environmental pollution.
In the early 1990s, at the height of the information technology and wireless communication boom, Maurice Fillion-Robin, a former executive in the pharmaceutical industry, became convinced that the biological effects of electromagnetic waves, already documented in numerous publications, were far from harmless and were disrupting the major systems of living organisms.
He hypothesized that it was possible to create technologies that improve compatibility between humans and EMFs.
He founded the Tecnolab research laboratory bringing together scientists and physicians to tackle a major challenge of the 21st century:
“Establishing electromagnetic compatibility between artificial EMFs generated by modern technologies and the human body”
By the late 1990s, pioneering research by Professors Brian David Josephson, Luc Montagnier, and Martin Chaplin revived Jacques Benveniste’s work on water memory, demonstrating that information can be stored and retrieved in aqueous solutions.
This opened the way to a deeper understanding of interactions between EMFs and water—the fundamental component of the human body.
Cyril Smith published « Electromagnetic Man: Health and Hazard in the Electrical Environment », described his collaboration with Dr. Jean Monro, which led to treatments
using electromagnetic frequencies emitted by aqueous solutions.
However, the effect of their solution only lasted 24 to 48 hours.
Building on by this work, Maurice Fillion-Robin’s team succeeded in making the signal permanent.
Through innovative methods, including digital dynamizations, they stabilized the solutions and ensured sustained emission over time.
From this breakthrough, the Compensating Magnetic Oscillator (CMO) technology was born, and the company Comosystems was later created to bring these protective solutions to the public.
What sets Comosystems apart is not only discovery and development, but also rigorous scientific validation. The company followed a methodology similar to that of the pharmaceutical industry: controlled studies, placebos, statistical analysis, collaboration with leading researchers, and peer-reviewed publications.
The complete list of these studies can be found here: (lien vers page publications)
11 professors participated in the biological and theoretical validation of CMO technology.
- Prof. Madeleine BASTIDE
- Prof. Vladimir N. BINHI
- Prof. Martin BLANK
- Prof. Laurence BONHOMME-FAIVRE
- Prof. Anthony G. CANAVAN
- Prof. Derek CLEMENTS-CROOME
- Prof. Reba GOODMAN
- Prof. Youri GRIGORIEV
- Prof. Marc HENRY
- Prof. Mikio MIYATA
- Prof. EUGENE V. STEPANOV
9 Doctors of Medicine and Science
- Dr Roger COGHILL
- Dr Gerard J. HYLAND
- Dr Jean-Luc MARANDE
- Dr. René MESSAGIER
- Dr. Marc Francois PAYA
- Dr Roger SANTINI
- Dr. Benoît-Jules YOUBICIER-SIMO
- Dr Jacques CATIER
- Dr Marie-Claire CAMAERTS-TRICOT
Research has been carried out in five countries: France, the UK, Japan, the USA, and Russia.
Importantly, Comosystems’ work is entirely independent of the telecommunications and energy industries, having never received external funding that could influence its results.
Today, Comosystems clearly displays its slogan :
“The historical and scientific reference for electromagnetic compensation”
and rightly so: this site makes more than twenty years of research available to the public and experts.
25 years of experiments conducted in university laboratories by scientific experts from around the world.
25 major reasons to protect yourself from the biological effects of electromagnetic fields in your environment and their possible consequences on your health.
20 irrefutable proofs of the protective effectiveness of CMO biotechnology.
Leadership and Team
In 2017, founder Maurice Fillion-Robin entrusted Comosystems to a new management team and now focuses on Quantiworld, its research partner since 2024.
Dr. René Messagier – Chief Executive Officer
Dr. René Messagier, a physician with multiple university diplomas (human physiology, homeopathy, acupuncture, auriculotherapy, nutrition, micronutrition, neurofunctional pathologies), has been involved in Tecnolab/Comosystems research since the 2000s.
He has authored works on EMF protection, coordinated international CMO studies, and is a member of the International Academy of Environmental Medicine.
In 2025, with Prof. Marc Henry, he co-authored the landmark reference:
“The Physics Principles of CMO Technology”.
See here:
Dr. Marc François Paya – Scientific Director
A medical doctor with expertise in acupuncture, homeopathy, osteopathy, auricular medicine, pain management, and disability assessment, Dr. Paya is also a former Head of Department at the Paris Nord Faculty of Medicine, Paris, France.
He has published widely on environmental health and nutrition, contributed to numerous patient associations, and lectures internationally.
He reinforces Comosystems’ scientific credibility in environmental health and EMF protection.
Miss Isabelle Fillion-Robin – Chief Financial Officer
With extensive experience in financial management, Isabelle oversees Comosystems’ strategic and operational financial activities, including budget planning, resource optimization, and financial reporting, ensuring the company’s stability and growth.
Dr. Bart De Wever – International Business Development
Dr. Bart De Wever, PhD in Medical Sciences, has over 25 years of experience in healthcare innovation and international business development.
At SkinEthic, he led the development of tissue-engineered skin and cornea models, regulatory-approved alternatives to animal testing, that resulted in the company’s IPO in 2004 and its acquisition by L’Oréal in 2006. Later, at bonyf, he drove the validation of anti-biofilmoral care products for gingivitis and peri-implantitis, and was key to the company’s IPO in 2023.
As Chief Scientific Officer at Zepter International and Co-author of Hyperlight Therapy, a reference work on innovative light-based medicine, translated into multiple languages, he supports Comosystems in expanding global partnerships and positioning innovative technologies in healthcare markets.
Carina Lehmann, European Business Development
Carina has a proven track record in business development with an increase of over 30% of turnover at Financial News, Intermedia and Ipercast and increasing companies international reputation through PR services among others at Turbohercules. For over 14 years she has recruited sales and marketing teams and created channel distribution networks leading to mergers and acquisitions.
Because Carina is electromagnically sensitive she experienced on-hand that the pain in her hand disappeared when using Comosystem’s CMO patch. She is therefore actively contributing in the European expansion of Comosystem and wishes to help a maximum of persons live in harmony with their electromagnetic environment.
The founder of Comosystems, Maurice Fillion-Robin, is now focusing on Quantiworld, which has been Comosystems’ research partner since 2024.
Quantiworld studies the properties of “informed” aqueous solutions, particularly using NIR spectrometry, in collaboration with leading experts in signal processing and quantum physics.
Manufacturing & Commitment
CMO devices have been produced for over 20 years by the same ISO 9001- and ISO 14001- certified industrial partner in Franche-Comté, France. This ensures the highest quality, safety, and sustainability standards.
Our goal is clear: to offer our customers effective biological protection against the risks associated with electromagnetic waves, while ensuring the quality, safety, and performance of our products.
At Comosystems, our mission is clear: to combine scientific rigor and technological innovation to provide reliable, accessible solutions that protect human health against the risks of electromagnetic exposure. Our values – innovation, transparency, and social responsibility – guide us in developing effective tools to address today’s environmental and health challenges.
With dedicated scientific, commercial, and financial teams, supported by a logistics hub in Florida ensuring fast distribution to the US market, Comosystems continues to grow as an
international reference in EMF protection.
This presentation reflects our identity: an innovative company, driven by a passionate team, which places scientific research at the heart of its development to better protect your health.